New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
LB Pharmaceuticals Inc (LBRX) vs Nuvation Bio Inc. (NUVB)
- LB Pharmaceuticals Inc LBRX 38.90 −2.80%
- Nuvation Bio Inc. NUVB 3.78 −0.79%
LB Pharmaceuticals Inc and Nuvation Bio Inc. are both Biotechnology companies. Nuvation Bio Inc. is the larger, with a market value of $1.4B against $1.3B — 1.1× the size. LB Pharmaceuticals Inc has the higher net margin (0.00% vs −67.4%) and the lower return on invested capital (−686.2% vs 0.00%). Across the 13 metrics below, LB Pharmaceuticals Inc leads on 8 and Nuvation Bio Inc. on 5.
Valuation
Profitability
| Metric | LBRX | NUVB | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 85.79% | 70.18% |
| Operating margin | 0.00% | (61.17%) | 0.00% |
| Net margin | 0.00% | (67.38%) | 0.00% |
| Free cash flow margin | 0.00% | (53.62%) | 0.00% |
| Return on equity | (38.80%) | (49.09%) | (51.58%) |
| Return on assets | (36.48%) | (19.70%) | (45.91%) |
| Return on invested capital | (686.18%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack